Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio

February 1, 2024

https://www.globenewswire.com/news-release/2024/02/01/2821962/0/en/Semper-Paratus-Acquisition-Corporation-s-Shareholders-Approve-Business-Combination-with-Tevogen-Bio.html

New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) — Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq:LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the “Business Combination”) with Tevogen Bio Inc, a Delaware corporation (“Tevogen Bio”), at an extraordinary general meeting of Semper Paratus’ shareholders that was held on Wednesday, January 31, 2024 (the “Meeting”).

Read more at globenewswire.com

Related news for (LGSTW)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.